| Tumour type | Mechanism | Cell type | Dosage | References |
| Lung caner | Apoptosis | H841, A549, PC14 | 1–40 μM | [17] | Colon caner | Apoptosis | HT-29 | 0–100 μM | [18] | Colon caner | Apoptosis | Caco-2 | 10–45 μM | [19] | Gastric cancer | Apoptosis, Cell cycle(G1) | MKN-7, MKN-28, MKN-45, AGS | 0.1–10 μM | [20] | Oral squamous cell Cancer | Apoptosis, Cell cycle(G2/M) | SCCa | 10 μM, 20 μM | [21] | Lung caner | Drug combination | A549, H460, female athymic nu/nu mice | 0–40 μM 1 mg/kg/day intraperitoneal | [24] | Colon caner | Apoptosis | HT-29, Caco-2 | 10 μM | [23] | Leukemic | Apoptosis | HL-60, K562, SNU-C4 | 0-20 μM | [22] | Gastric cancer | Inhibition of Ang-1 | MKN45, HUVEC | 0–10 μM | [25] | Renal caner | Apoptosis, Inhibition of VEGF | SMKT-R-1, R-2, R-3, and R-4, | 0–50 μM | [26] | Lymphoma | Inhibition of COX-2 | U937, BAEC | 0–10 μM | [27] | Oesophageal cancer | Apoptosis, Cell Cycle(G1) | TE-7 | 0–10 μM | [29] | Endometrial cancer | Apoptosis, Cell Cycle(G2/M) | HHUA, HEC-59 | 0–20 μM | [30] | Breast caner | Apoptosis, Cell Cycle(G2/M) | MCF-7 | 0–10 μM | [31] | Breast cancer | Invasion | MDA-MB-231 | 5 μM | [32] | Pancreatic cancer | Invasion | AsPC-1, SUIT-2 BxPC-3, MIA PaCa-2, Panc-1 | 0–25 μM | [33, 34] | Colon caner | Cell Cycle(G1), Invasion | SW480, LS174T | 0–40 μM | [35] | Colon caner | Invasion | HT-29 | 0–30 μM | [10] | Brain tumour | Inhibition of stem cells | U87MG, T98G | 0–10 μM | [37] |
|
|